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Abstract
Background: Disease progression in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE),
as one of its animal models, is characterized by demyelination and neuronal damage in white and gray matter structures,
including the hippocampus. It is thought that dysfunction of the hippocampus, a primary locus of learning and memory
consolidation, may contribute to cognitive impairment in MS patients. Previously, we reported an increased generation
of hippocampal neuronal progenitors in the acute stage of EAE, whereas the microenvironmental signals triggering
this process remained uninvestigated.
Results: In the present study, we used the Wnt signaling reporter mouse Axin2LacZ, to elucidate the molecular
mechanisms underlying the activation of the hippocampal neurogenic niche upon autoimmune neuroinflammation.
Histological and enzymatic examinations of β-gal during the disease course of EAE, allowed us to survey hippocampal
Wnt/β-catenin activity, one of the key signaling pathways of adult neurogenesis. We found that Wnt signaling is
transiently upregulated in the acute stage of disease, consistent with a timely induction of canonical Wnt ligands.
The enhancement of signaling coincided with hippocampal neuronal damage and local expression of immune
cytokines such as TNFα and IFNγ, implicating the role of the inflammatory milieu in activation of the Wnt/β-catenin
pathway. Supporting this finding, we show that transient exposure to pro-inflammatory cytokine TNFα triggers Wnt
signaling in hippocampal organotypic slice cultures. Importantly, inflammation-mediated activation of the Wnt/β-catenin
pathway was associated with enhanced neurogenesis in vitro and in vivo, indicating its potential role in hippocampal
tissue regeneration and repair.
Conclusions: This study raises the possibility that enhancement of Wnt signaling may support neurogenic processes to
cope with neuronal deficits upon immune-mediated neuroinflammation.
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Background
A large body of research highlights the involvement of hip-
pocampal pathology in cognitive disability that is com-
monly observed in patients with multiple sclerosis (MS),
an inflammatory demyelinating and neurodegenerative
disease of the central nervous system (CNS) [1, 2]. Struc-
tural changes in the hippocampus were shown to be
associated with MS-related memory impairment [3] and
may occur prior to cognitive dysfunction [4, 5], suggesting
a therapeutic opportunity for reversing memory decline in
MS patients (reviewed in [5–7]). Examinations of neuro-
biological alterations in post-mortem brain tissue indicate
frequent and extensive hippocampal demyelination [8]
resulting in alterations of synaptic function, axonal trans-
port [9] and neuronal loss in the Ammon’s horn 1–3
(CA1-3) regions [9, 10]. Furthermore, axonal demyelin-
ation was shown to be accompanied by drastic changes in
the expression of specific neuronal genes [9] and neuronal
miRNA [11] suggesting disturbance of molecular pathways
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involved in physiological homeostasis of hippocampal tis-
sue. Experimental autoimmune encephalomyelitis (EAE),
an animal model of MS, mimics many aspects of hippo-
campal pathology and its clinical expression in the human
disease such as demyelination, alteration in synaptic plasti-
city and transmission [12, 13], neuronal loss [12], cognitive
deficits [14] and thus, becomes an important model for
the characterization of mechanisms involved in hippocam-
pal neuropathology and MS-related memory deficits. Our
previous data identified adult hippocampal neurogenesis,
an important player in cognition [15], as a primary target
of autoimmune-mediated neuroinflammation [16]. The
analysis of hippocampal gene expression in acute and
chronic stage of EAE revealed alterations in the tran-
scriptional profile of genes relevant for key neurogenic
pathways in the adult brain, including those of Wnt sig-
naling [16]. Considering the potential role of the Wnt
pathway in tissue renewal and regeneration [17, 18], we
here examined the impact of autoimmune neuroinflam-
mation on hippocampal Wnt/β-catenin activity by using
Axin2lacZ/+ reporter mice. We found that T cell-mediated
autoimmune neuroinflammation leads to hippocampal
neuronal damage occurring early in disease progression
and may potentially trigger the activation of Wnt signaling
via upregulation of a specific set of Wnt ligands. Transient
increase in the Wnt activity in the acute phase was as-
sociated with increased proliferation and generation of
doublecortin-positive (Dcx+) neuronal precursor cells.
Further, we identified the inflammatory mediator tumor
necrosis factor alpha (TNFα) as a potent enhancer of
Wnt signaling activity and subsequently, the prolifera-
tion of progenitor cells in the hippocampal neurogenic
niche.
Results
Increased Wnt activity in the acute phase of EAE
In the adult brain, Wnt signaling pathway is persistently ac-
tive in the hippocampus and is of high importance for
homeostatic neurogenesis [19]. To evaluate the impact of
autoimmune-mediated neuroinflammation on hippocampal
Wnt/β-catenin signaling we induced EAE in Axin2lacZ/+
reporter mice by immunization with an encephalito-
genic CNS self-antigen, myelin oligodendrocyte glycopro-
tein (MOG35–55) peptide. Like other feedback inhibitors in
various pathways, Axin2 is induced in response to the Wnt
signaling cascade and is widely used as readout of Wnt/β-
catenin activity. Mutant mice, lacking one functional Axin2
allele, are born normal and upon immunization developed
typical non-remitting chronic EAE with a disease onset at
11–12 days post immunization (d.p.i.). (Fig. 1a). Histo-
logical examinations revealed the occurrence of typical
perivascular infiltrates, predominantly in the white mat-
ter of the spinal cord (Additional file 1: Figure S1a-b).
These infiltrates were characterized by increased Iba1
immunoreactivity (the marker for microglia and macro-
phages). Interestingly, microglia activation was evident
in the hippocampus and particularly in the hippocam-
pal subgranular zone (SGZ). In this region, microglia
were localized in close proximity to SOX2/GFAP-
double positive cells with prototypical morphology of
radial glia-like cells (RGCs or type-1 cell) and horizon-
tal progenitors, both the primary stem cells of the adult
dentate gyrus (DG) (Fig. 1b and Additional file 1: Figure
S1d) [20, 21]. Despite the rare occurrence, we also found
perivascular lesions enriched with Iba1 immunoreactive
cells located in close proximity to the SGZ, the germina-
tive zone of the hippocampal DG (Additional file 1: Figure
S1c). Analysis of β-galactosidase (β-gal) activity in Axin2-
lacZ/+ mice showed the enhancement of Wnt signaling in
the hippocampal tissue at days 20 and 30 after disease in-
duction (1.31–1.78 fold), while at day 50 its activity re-
sumed to the levels observed in control CFA/PTX-
immunized mice (Fig. 1c). In the spinal cord, increased
Wnt signaling was observed in all disease stages examined
(Fig. 1c), whereas no significant changes were detected in
the frontal/motor cortex (Additional file 1: Figure S1e),
the area that was virtually not affected by inflammation.
Only modest increase in β-gal activity was observed in
the cerebellum (Additional file 1: Figure S1f). Of note,
only trace amounts of β-gal activity were detected in naive
or EAE tissue from wt (Axin2+/+) mice (data not shown),
proving the accuracy of the β-gal measurements and the
minor impact of senescence-associated processes. Add-
itionally, we confirmed the results of the β-gal assay in the
spinal cord and different parts of the brain by qPCR ana-
lysis of the Axin2 gene expression in the acute stage of
EAE (Additional file 1: Figure S1g). The distribution pat-
tern of LacZ expression in the DG examined by X-gal
staining revealed increased signal intensity mostly in cells
of the granular layer including the SGZ and in some cells
of the hilus (Fig. 1d). β-gal activity in the hippocampal and
spinal cord tissues positively correlated with clinical dis-
ease score in individual mice (Additional file 1: Figure
S1.h, Pearson correlation, r = 0.58; p = 0.018 and r = 0.52;
p = 0.036, respectively). Taken together, our results re-
vealed a brain area-specific and disease severity-
dependent upregulation ofWnt signaling in EAE mice.
Next, we examined the activation state of Wnt signal-
ing mediators in naive and EAE mice. The ligation of
Wnts inducing the canonical pathway leads to stabilization
(de-phosphorylation) of β-catenin via inactivation (phos-
phorylation at Ser9) of GSK-3β, a member of the β-
catenin destructive complex. Supporting the results of the
enzymatic assay, we found a significant increase in active
β-catenin (ABC)/total β-catenin ratio at day 30 of EAE
mice in comparison to their respective controls (Fig. 1e).
Taken together, our results indicate a transient upregula-
tion of hippocampal Wnt signaling in acute stages of EAE
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Fig. 1 Analysis of Wnt activity in EAE. a Disease course in Axin2lacZ/+ mice with chronic EAE. EAE was induced by immunization with MOG35–55.
Control group (CFA) were injected with an adjuvant cocktail without antigen. Data are shown as a mean clinical score ± SEM. Blue columns
indicate the time points when mice were sacrificed for analysis: days 20, 30 and 50 post immunization. b Representative image of Iba1, GFAP
co-immunostaining in hippocampal section of an EAE mouse at day 30. White arrow heads indicate reactive microglia Iba1+ (red) located in
close proximity to radially oriented GFAP+ cells (green; yellow arrow heads) resembling radial glia progenitor cells of the SGZ. Nuclei were
counterstained with Hoechst (blue). Scale bar: 100 μm. c β-gal assay of hippocampal and spinal cord tissue. Histogram represents mean + SEM
of fold-changes of β-gal activity in EAE mice relative to respective controls (CFA) set as 1. Day 20 (EAE, n = 6; CFA, n = 3); day 30 (EAE, n = 4;
CFA, n = 3); day 50 (EAE, n = 8; CFA, n = 4). Two-tailed, unpaired Student’s t-test, *p < 0.05. d Upregulation of Axin2 expression in the DG of EAE
mice. Expression of lacZ and thus activation of Axin2 promoter were detected by X-gal staining on hippocampal sections from EAE mice (day
20) and respective controls (CFA). Representative images are shown. Top insets show magnified cells of the outlined SGZ region. Arrow heads
mark X-gal positive cells. Gcl, granular cell layer. Scale bar, 100 μm. e Immunoblot analysis of β-catenin in the hippocampus of EAE and control
(CFA) animals. Hippocampal proteins were extracted and processed for Western blotting with antibodies against active β-catenin (ABC) and total β-
catenin. β-actin was probed for analysis of protein loading. Right histogram represents mean + SEM of fold-changes of normalized optical densities in
EAE mice relative to controls (CFA) set as 1. Day 20 (n = 6); day 30 (n = 4); day 50 (n = 6) and control CFA mice (n = 6). Two-tailed, unpaired Student’s t-
test, *p < 0.05 and ** p < 0.01
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(20–30 d.p.i.). In contrast to this, sustained increase in
Wnt activity was observed in the spinal cord through all
EAE stages examined (Fig. 1c), which was correlated with
a large number of inflammatory foci (Additional file 1:
Figure S1a-b).
Induction of Wnt ligands in passive EAE
The Wnt gene family encodes for 19 cysteine-rich se-
creted signaling molecules. To determine the particular
Wnt ligands activated in the hippocampi of EAE mice,
we performed Wnt gene expression profiling analysis.
To exclude possible confounders associated with an ac-
tive immunization process, this examination was per-
formed in the passive model of EAE induced by adoptive
transfer of myelin specific T cells (Fig. 2a). As a first re-
sult, we noticed a transient upregulation of hippocampal
Axin2 on the transcriptional level (Fig. 2b). This obser-
vation extends our findings from actively immunized
Axin2lacZ/+ mice and is indicative of enhanced Wnt sig-
naling in the acute stage of disease independent from
immunization process. Notably, induction of Axin2 mes-
senger RNA (mRNA) expression has occurred neither prior
to the onset of disease (day six after adoptive transfer) nor
in the chronic stage (day 50) (Fig. 2b). At day 20, EAE mice
exhibited higher mRNA levels of a number of Wnt genes
relevant for the canonical β-catenin/TCF pathway (Wnt2,
Wnt3, Wnt3a, Wnt8b, Wnt9a and Wnt16; fold inductions
ranging from 2 to 6) and those signaling through β-
catenin-independent mechanisms (Wnt4, Wnt5a, Wnt5b;
fold inductions ranging from 1.5 to 3.5) (Fig. 2c). Other
Wnt ligands found to be expressed in the hippocampus
(Wnt7a, Wnt7b, Wnt10a, Wnt11) exhibited no signifi-
cant differences compared to controls (Additional file 2:
Figure S2a). We also elucidated the gene expression pro-
file of up-regulated Wnt ligands in other CNS regions of
EAE mice. In the acute stage, we found an induction of
Wnt2, Wnt3, Wnt5a, Wnt5b in the spinal cord tissue and
Wnt5a in the cerebellum (Additional file 2: Figure S2b).
As it was observed in actively-immunized mice (Fig. 1c),
the transcriptional levels of Wnts in the chronic stage of
passive EAE returned to the levels detected in control ani-
mals (injected with PBS) confirming the transient profile
of enhanced Wnt signaling (Fig. 2b, c). Consistent with
previous reports in other CNS regions [22, 23], our data
revealed that the acute phase of EAE is associated with







































































Fig. 2 Gene expression analysis of Wnts in the hippocampus of EAE mice. a Disease course in passively transferred EAE. Female SJL/J mice
received activated encephalitogenic T lymphocytes derived from immunized donors and re-stimulated with encephalitogenic PLP139–151 peptide.
Control mice were injected with PBS. Data are shown as mean clinical score ± SEM. Grey columns indicate the time points when mice were sacri-
ficed for analysis: days 6, 20 and 50 after adoptive transfer. b qPCR analysis of Axin2 gene expression in the hippocampus of mice with passively
transferred EAE. Data represent mean of fold-changes + SEM of gene expression in EAE mice relative to respective controls set as 1. Expression of Axin2
was normalized to Gapdh. Day 6 (EAE, n = 5; control, n = 4); day 20 (EAE, n = 6; control, n = 8); day 50 (EAE, n = 12; control, n = 11). Two-tailed, unpaired
Student’s t-test, *** p < 0.001. c qPCR analysis of selected Wnts genes in the hippocampus at early (day 20) and chronic (day 50) stages of passive EAE.
Histogram represents mean + SEM of fold-changes relative to control group set as 1. Gene expression was normalized to Gapdh. Day 20 (EAE, n = 4–6;
control, n = 4); day 50 (EAE, n = 8–13; control, n = 7–11). Two-tailed, unpaired Student’s t-test, * p < 0.05, ** p < 0.01 and *** p < 0.001
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Upregulation of Wnt activity correlated with neuronal
injury and inflammatory processes
Upregulation of Wnt signaling pathway members was
observed in early stages of various pathologies associated
with inflammation-mediated tissue injury [17, 18]. To
take a closer look at hippocampal neuronal injury in
early and late stages of EAE, we analyzed the expression
of the axonal marker neurofilament-H (NF-H) and the
postsynaptic density protein-95 (PSD-95). The protein
levels of PSD-95 were diminished throughout all stages
of disease, reflecting the reduction in the number of hip-
pocampal synapses (Fig. 3a). We also found a persistently
decreased protein level of NF-H (Fig. 3a), indicating that
early neuronal injury is not compensated for in the chronic
stage of non-remitting EAE (Fig. 1a). Early neuronal dam-
age was associated with active inflammatory processes, as
suggested by an elevated number of Iba1-positive cells
(Fig. 3b-c), immunoreactivity for activation markers MHC
class I (Fig. 3b), CD68 (Fig. 3e) and significant upregula-
tion of gene transcription of inflammatory mediators
(TNFα, IFNγ and interleukin-1 beta (IL-1β)) (Fig. 3f). Of
note, strong positive correlation was observed between the
transcriptional level of Axin2 and TNFα mRNA in individ-
ual mice (Additional file 2: Figure S2.c, Pearson correl-
ation, r = 0.845; p < 0.001).We also found a significant
induction of mRNA levels of transforming growth factor 1
beta (TGFβ1) (Fig. 3f) and Smad7 (Additional file 2: Figure
S2d), the negative feedback regulator of TGFβ signaling.
Upregulation of hippocampal TGFβ signaling in early
stages of EAE is consistent with its CNS specific role in
disease initiation [24]. In contrast to the significant in-
crease in microglia number in the acute stage, the number
of astrocytes remained unaffected by neuronal injury; how-
ever, it was significantly increased in the chronic stage
(Fig. 3d). Together these data indicate that the upregula-
tion of Wnt activity described above coincides with occur-
rence of neuronal damage and inflammatory processes at
the early stage of disease, whereas in the chronic stage it
returned to the basal level.
Wnt signaling promotes neurogenic processes in the DG
In the adult brain, the Wnt/β-catenin pathway regulates
proliferation and self-renewal of hippocampal stem/pro-
genitor cells [19]. Therefore, we next asked if the increased
Wnt activity in EAE may trigger proliferation and gener-
ation of hippocampal neuronal precursor cells. First, in
mice with passively induced EAE, we examined the gene
expression of pro-neurogenic transcription factors, known
to be regulated by β-catenin/TCF transcriptional activity.
We found that the increase of Wnt activity during the
early stage of disease (day 20) correlates with an upregula-
tion of Neurogenic differentiation 1 (NeuroD1), prospero
homeobox 1 (Prox1), distal-less homeobox 2 (Dlx2) and
lymphoid enhancer-binding factor 1 (Lef1) mRNA levels
(Fig. 4a). Next, we used the BrdU labeling approach to
mark dividing progenitors in the hippocampus and to
trace the cell fate of newborn cells. Considering the early
induction ofWnt signaling (Fig. 1c), we administered BrdU
at 15 d.p.i. for five consecutive days, followed by a period
of 2-weeks without BrdU treatment (Fig. 4b). We found
a significant increase in the total number of label-
retaining cells in the DG of EAE mice (14 ± 2 cells/mm)
in comparison to control mice (10 ± 1 cells/mm). Simi-
larly, the number of newly generated neuroblasts, mea-
sured by co-labeling of BrdU+-retaining cells with the
neuronal progenitor marker Dcx, was increased twofold
in EAE mice (8 ± 2 cells/mm in EAE mice; 4 ± 1 cells/mm
in control mice) (Fig. 4c-d). Taken together, these results
support our previous findings indicating an enhanced de
novo generation of hippocampal neuronal progenitors in
EAE mice [16] and are consistent with the notion that
augmented Wnt activity in the hippocampus is relevant
for activation of neurogenesis in acute disease stages.
Effects of TNFα on the Wnt signaling and hippocampal
neurogenesis
Though the induction of Wnt signaling was previously re-
ported in the context of various tissue damage paradigms
[17, 18], the mechanisms triggering the Wnt pathway
remain unknown. Therefore, we used the Axin2lacZ/+ re-
porter mice to characterize the possible contribution of
particular cytokines, known to be secreted by activated
microglia, to promoteWnt activity in neural tissue.
We switched our experimental setup to hippocampal
slice cultures, which represent a useful model to study
neurogenic processes ex vivo [25]. We focused on the role
of TNFα and IFNγ, because their expression was signifi-
cantly induced in the hippocampus of EAE mice (Fig. 3c)
and because of independent findings on their potential
contribution in tissue regeneration during demyelinating
pathology [26–28]. Similar to freshly isolated hippocampal
tissue (Fig. 1d), the pattern of Wnt activity in cultured
slices examined by X-gal staining was mostly confined to
the neuronal compartment of the granular layer (Add-
itional file 3: Figure S3a). Treatment with TNFα or Wnt3a
(used as a positive control [29, 30]) for 6 h and subsequent
incubation of Axin2lacZ/+ slices in cytokine-free media for
24 h led to a significant upregulation of Wnt activity
(1.56 ± 0.20 fold and 2.39 ± 0.18 fold, respectively)
(Fig. 5a). The increase of Wnt signaling was limited to
this particular immune cytokine, as the treatment with
IFNγ did not have a similar effect. We then investigated
whether TNFα may have a direct effect on the induc-
tion of Axin2 in cultured hippocampal progenitor cells.
However, the treatment with TNFα was not associated
with upregulation of Axin2 transcription (Additional
file 3: Figure S3b). In contrast, Wnt3a potently induced
Axin2 gene expression in these cells (Additional file 3:




Fig. 3 (See legend on next page.)
Schneider et al. Molecular Neurodegeneration  (2016) 11:53 Page 6 of 16
Figure S3b). This result led us to the hypothesis that
enhancement of Wnt signaling in slice cultures is medi-
ated via an indirect effect of the cytokine on other cell
types. To test this, we separated hippocampal astrocytes
(GLAST+) and microglia (CD11b+) from mixed glial
cultures using microbeads-based sorting procedure and
exposed them to TNFα. Analysis of gene expression of
Wnt ligands found to be upregulated in acute stage
(Fig. 2c) revealed that TNFα significantly induced the
expression of Wnt2, Wnt3 and Wnt5a in astrocyte cul-
tures and Wnt3 and Wnt5a in microglia cultures (Add-
itional file 3: Figure S3c). We further investigated the
effect of inhibition of endogenousWnt ligand secretion on
the induction of Axin2 in hippocampal slice cultures.
Treatment with TNFα enhanced Axin2 expression
(Fig. 5b), supporting our results of the β-gal assay (Fig. 5a).
Co-treatment with IWP-2 inhibitor, that inactivates por-
cupine and suppresses the secretion of Wnt ligands [31],
potently abrogated the positive effect of TNFα (Fig. 5b).
Taken together, these data suggest a role of Wnt ligands in
TNFα-mediated upregulation of hippocampal Wnt
signaling.
We next asked whether TNFα affects hippocampal
neurogenesis and whether Wnt ligands contribute to this
effect. To assess the proliferation rate of hippocampal
progenitors in NestineGFP hippocampal slice cultures, we
labeled mitotically active cells with BrdU prior to 6 h
treatment with the individual cytokines. After a 24-h
chase in cytokine-free media the quantification of BrdU-
retaining cells was examined. Treatment with TNFα
(Fig. 5c-d) or Wnt3a, but not IFNγ (Additional file 3:
Figure S3d-e), led to a significant increase in the num-
ber of BrdU+/eGFP+ neural progenitor cells. Inhibition
of Wnt ligand secretion by IWP-2 suppressed the pro-
liferative effect of TNFα (Fig. 5c-d). We further con-
firmed these results using co-culture experiments. For
this approach we used hippocampal microglia because
of its prominent activation pattern during the EAE pro-
gression (Fig. 3b-c). CD11b-sorted hippocampal micro-
glia cultured on transwell inserts were activated with
TNFα for 6 h. After several washing steps, transwells
were set onto hippocampal progenitor cultures in pro-
liferating conditions in the presence or absence of soluble
Frizzled-8-Fc protein (sFz8). This recombinant protein
contains a conservative cysteine-rich region (CRD) and
was efficiently used to block Wnt ligand binding in hippo-
campal progenitor cultures [30]. After 24 h, mitotic cells
were labeled with BrdU (2 h treatment). TNFα -primed
microglia significantly enhanced mitotic activity of SOX2+
progenitor cells (Fig. 5e-f). Blockade of Wnt signaling with
sFz8 decreased the proliferating rate to the level observed
in progenitors co-cultured with non-activated microglia in
the presence of sFz8. Taken together, these results are
consistent with the observation that TNFα promotes Wnt
signaling to enhance the initial steps of the hippocampal
neurogenic program. In part, this effect is mediated
through microglia-dependent Wnt ligand production, sup-
porting the pro-neurogenic role of activated microglia in
the hippocampus [32–34].
Discussion
The discovery of Wnt pathway activity in the adult CNS
in physiological and pathological conditions has raised
new questions about the mechanism of its activation.
Moreover, it is of therapeutic interest whether the unique
involvement of the Wnt pathway in developmental pro-
cesses (such as neurogenesis, oligodendrogenesis, synapto-
genesis and axonal guidance) may be useful for facilitation
of tissue renewal and repair.
In the present study we made use of Axin2lacZ/+ reporter
mice to monitor the dynamic changes in hippocampal
Wnt activity upon acute and chronic stages of EAE, an
animal model of MS. Our major finding is that CNS path-
ology, relevant for acute tissue injury and inflammation, is
associated with a transient increase of hippocampal Wnt
signaling. Enhanced Wnt/β-catenin activity was correlated
with transient upregulation of canonical Wnt ligand
(Wnt2, Wnt3, Wnt3a, Wnt8b and Wnt9a) mRNA levels.
We also show that TNFα, an inflammatory cytokine up-
regulated in the hippocampus of EAE mice (Fig. 3d), can
(See figure on previous page.)
Fig. 3 Neuronal damage and neuroinflammation in the hippocampus of EAE mice. a Immunoblot analysis of neuronal proteins in the
hippocampus of Axin2lacZ/+ EAE and control (CFA) animals. Hippocampal proteins were extracted and processed for Western blotting with
antibodies against neurofilament-H (NF-H) and postsynaptic protein 95 (PSD-95). β-actin was probed for analysis of protein loading. Right histogram
represents mean + SEM of fold-changes of normalized optical densities in EAE mice relative to controls (CFA) set as 1. Day 20 (n = 6); day 30 (n = 4);
day 50 (n = 6) and control CFA mice (n = 6). Two-tailed, unpaired Student’s t-test, *p < 0.05 and ** p < 0.01 b Representative image of Iba1, GFAP and
MHC class I co-immunostaining in a hippocampal section of an EAE mouse and a healthy control at day 20. The insets on the right show magnified
Iba1+ macrophage/microglia cells (red) co-labelled with MHC class I (blue). Nuclei were counterstained with Hoechst (grey). Scale bar: 50 μm and
10 μm. c-d Quantification of Iba1+ (c) and GFAP+ (d) cells in the DG of EAE (n = 4) and control (n = 4) mice. Data represents mean + SEM. Two-tailed,
unpaired Student’s t-test, * p < 0.05. e Representative image of Iba1, CD68 co-immunostaining in the DG of EAE mouse at day 20. The insets on the
right show magnified microglia cells (green) co-labelled with the activation marker CD68 (red). Nuclei were counterstained with Hoechst (grey). Scale
bar: 50 μm and 10 μm. f qPCR analysis of gene expression of inflammatory cytokines in the hippocampus at early (day 20) and chronic (day 50) stages
of EAE. Histogram represents mean + SEM of fold-changes relative to control (CFA) group set as 1. Expression was normalized to Gapdh. Day 20 (EAE,
n = 3–6; control, n = 3–8); day 50 (EAE, n = 9–10; control, n = 6–7). Two-tailed, unpaired Student’s t-test, * p < 0.05, ** p < 0.01 and *** p < 0.001
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be considered as a potent factor contributing to Wnt
signaling activation. Furthermore, the induction of Wnt
activity led to increased proliferation of neuronal pro-
genitors and generation of Dcx+ neuronal precursor
cells (also known as Type2b). Taken together, our study
revealed a link between neuroinflammation and Wnt-
dependent activation of hippocampal neurogenesis re-
garding the tissue repair program.
Our finding that activation of Wnt signaling is medi-
ated by active inflammatory processes is in line with
previous reports on MS pathology. Using different bio-
chemical techniques, the upregulation of Wnt ligands
(Wnt2, Wnt7a: microarray data [35]); Wnt3a: prote-
omic analysis [36]) and Wnt pathway members such as
Axin2 (histological examination [37]), GSK-3β, β-catenin
and Tcf4 (proteomic analysis [36]) was demonstrated in
active plaques in the white matter and was absent in
chronic silent plaques or normal-appearing white matter.
In the EAE model, transient induction of Wnt1 was
demonstrated in the subventricular zone (SVZ) of the lat-
eral ventricle [23].
We found that the upregulation of Wnt/β-catenin ac-
tivity in the hippocampus is associated with an induc-
tion of several canonical Wnts involved in self-renewal
and cell fate determination of stem/progenitor cells,
synaptic plasticity, axon guidance and tissue homeosta-
sis (reviewed in [38, 39]). Thus, Wnt3 and Wnt3a are
potent activators of self-renewal and neuronal fate in
the adult hippocampus [19, 29] and cultured neural pro-
genitor cells [30]. Wnt2 enhances neurogenesis in the de-
veloping brain [40] and its induction in the dentate gyrus
after electroconvulsive seizures (ECS) [41] was reported to
be associated with increased hippocampal neurogenesis
[42]. Wnt8b regulates dorsal thalamic neurogenesis during
zebrafish development [43] and was also shown to en-
hance the proliferation of cultured rat adult hippocampal
progenitors [30]. Expression of Wnt16a (human analogue

































































Fig. 4 Hippocampal neurogenesis is increased in the acute phase of EAE. a Induction of pro-neuronal transcription factors in the hippocampus of
mice with passive EAE. qPCR analysis of the Wnt-dependent genes (NeuroD1 (ND1), Prox1, Lef1) and Dlx2, a marker of transient amplifying neuroblasts.
Histogram represents mean + SEM of fold-changes in gene expression of EAE mice relative to control (PBS) group set as 1. Gapdh was used as an
endogenous reference. Day 20 (EAE, n = 4–8; control, n = 4–8); day 50 (EAE, n = 4–10; control, n = 4–11). Two-tailed, unpaired Student’s t-test, * p < 0.05,
** p < 0.01 and *** p < 0.001. b Disease course of C57/B6 EAE mice immunized with encephalitogenic MOG35–55. Control group (CFA) were injected
with an adjuvant cocktail without antigen. Data are shown as a mean clinical score ± SEM. In acute phase of disease (days 15–20; highlighted by green
line) EAE and respective control mice received daily i.p. injections of BrdU (50 mg/kg body weight). After a 2-weeks chase period without administration
of BrdU mice were sacrificed for histological assessment (day 30). c Histological analysis of proliferating cells in the DG of EAE mice. Immunostaining for
BrdU (green) and Dcx (red) in hippocampal sections. Arrow heads indicate BrdU+/Dcx+ co-labeled neuronal progenitors. Nuclei were counterstained
with Hoechst (grey). Scale bar, 50 μm. d The frequency of BrdU label-retaining cells in the DG is increased in mice with EAE (day 30; n = 3 mice; 18–28
sections per mouse) as compared to control mice (n = 3 mice; 17–28 sections per mouse). Data is shown as mean + SEM of positive cells per mm of the
DG. Two-tailed, unpaired Student’s t-test,* p < 0.05 and ** p < 0.01








































































































































































Fig. 5 Analysis of Wnt activity in organotypic slice cultures (OSCs). a β-gal assay. Hippocampal Axin2lacZ/+ OSCs were treated for 6 h with Wnt3a
(20 ng/ml), TNFα (1 ng/ml) or IFNγ (100 U/ml) and the medium was replaced with fresh cytokine-free medium for additional 24 h. Histogram
represents mean + SEM of fold-changes of β-gal activity after treatment with Wnt3a (n = 15), TNFα (n = 14) or IFNγ (n = 14) relative to controls
(PBS, n = 20) set as 1. Two-tailed, unpaired Student’s t-test, * p < 0.05 and *** p < 0.001. b qPCR analysis of the Axin2 gene expression. OSCs
were treated as described above. IWP-2 (4 μM) was present in the media during the whole experiment. Histogram represents mean + SEM of
fold-changes in Axin2 gene expression after treatment with Wnt3a (n = 3), TNFα (n = 4) or TNFα with IWP-2 (n = 3) relative to control (PBS,
n = 4) OSCs set as 1. Gapdh was used as an endogenous reference. Two-tailed, unpaired Student’s t-test, * p < 0.05. c-d Histological analysis of
proliferating cells in the DG of hippocampal NestineGFP OSCs. BrdU was administered to slice culture for 24 h prior to treatment with cytokines
(performed as described for Fig. 5a-b). c Representative images show the immunostaining for BrdU (red) and eGFP (green). Arrow heads indicate
BrdU+/eGFP+ co-labeled hippocampal progenitors. Scale bar, 50 μm. d Inhibition of Wnts secretion with IWP-2 (4 μm) abrogates the proliferative effect
of TNFα on mitotic activity of hippocampal eGFP+ progenitors. Data are shown as mean + SEM of BrdU+ or BrdU+/eGFP+ co-labeled cells per mm of
the DG. Control (PBS, n = 20 slices); TNFα (n = 9 slices), IFNγ (n = 11 slices) and Wnt3a (n = 9 slices); Two-tailed, unpaired Student’s t-test, * p < 0.05,
** p < 0.01 and *** p < 0.001. e-f TNFα - activated hippocampal microglia promotes the proliferation of hippocampal progenitors in vitro.
Microglia cultured on transwell inserts were primed by TNFα (1 ng/ml) for 4 h. Transwells were set onto the hippocampal progenitor cultures
in proliferating medium containing 5 ng/ml of bFGF in the presence or absence of soluble Frizzled-8 (Fz8; 1 μg/ml). After 24 h dividing cells
were labelled with BrdU (2 h) and cells were fixed for immunocytochemistry. e Representative images of SOX2+ (blue) hippocampal progenitors
stained for BrdU (red). Scale bar, 25 μm. f Quantification of BrdU-retaining SOX2+ cells. Data are shown as mean of four experiments + SEM. Two-tailed,
unpaired Student’s t-test,* p < 0.05
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its role in the CNS remains to be examined. Considering
the transient induction of Wnt16 and activation of Wnt/β-
catenin pathway at the early stage of osteoarthritis [45], it
is plausible to assume that Wnt16 mediates the response
to neural tissue injury via promotion of β-catenin signal-
ing. Remarkably, in addition to their role in neural plasti-
city, Wnts likely participate in neuroimmune interactions
(reviewed in [46]).
Consistent with previous reports demonstrating the up-
regulation of different components of canonicalWnt path-
way in various models of acute spinal cord pathology
(such as EAE [22], spinal cord injury [47] and
lysolecithin-induced demyelination [37]), we found the
enhancement of Wnt/β-catenin signaling in the spinal
cord of Axin2lacZ/+ EAE mice. Notably, in this part of
the CNS Wnt activity was increased throughout the
course of disease and correlated with a large number of
inflammatory foci (Additional file 1: Figure S1b), indi-
cating ongoing active inflammatory processes. Thus, it
is conceivable that the new waves of inflammation-
mediated damage trigger the persistent activation of
Wnt signaling in the spinal cord.
In line with the idea that acute inflammation enhances
Wnt signaling, we showed that TNFα is a potent inducer
of Wnt activity in hippocampal slice cultures. This finding
is consistent with previous reports demonstrating the inter-
play between those two signaling pathways in other cellular
contexts [48–51]. Notably, increased proliferation and in-
duction of Wnt genes (such as of Wnt3, Wnt5a, β-catenin)
was observed upon TNFα-induced trans-differentiation of
human mesenchymal stem cells towards the neural lineage
[52]. Taking advantage of hippocampal slice cultures as a
useful model to study neurogenic processes ex vivo [25],
we also demonstrated that TNFα-dependent activation of
the Wnt pathway induces the proliferation of Nestin+ pro-
genitor cells in the DG,and this effect is mediated via
production ofWnt ligands. We further consider hippocam-
pal microglia as the responder cells to TNFα-dependent
enhancement of Wnt signaling, although other targets of
TNFα may also mediate its effect on adult neurogenesis.
While the mechanism remains to be elucidated, our data is
in line with the role of TNFα-TNFR2 signaling in hippo-
campal neurogenesis in healthy mice [53] and upon various
CNS pathologies. Thus, in the model of status epilepticus,
deficiency for TNFR2 drastically abrogates the number of
newly generated neurons in the hippocampus [54], though
not in the SVZ [55]. Complementary to these findings,
infusion of neutralizing antibodies against TNFα had an
anti-proliferative effect on hippocampal progenitors in a
rat model of stroke [56]. In cultured progenitor cells, TNFα
potentially triggers the proliferation of neural stem/pro-
genitor cells [57–59].
Understanding the role of TNFα in MS is complex and
has been re-considered in the last years [60, 61]. While
anti-TNFα therapy has been used successfully to treat
various autoimmune pathologies, it was proven to be dele-
terious in MS patients [62]. The aggravation of EAE in
TNFR2-deficient mice, particularly in the chronic phase
[63], may indicate a principal involvement of the TNFα-
TNFR2 axis in processes of regeneration and tissue repair.
Supporting this idea, recent findings demonstrated the
beneficial effect of TNFα/TNFR2 signaling on expansion
of the endogenous pool of oligodendrocyte progenitors
and subsequent remyelination in a toxin-induced demye-
linating model [26].
Activation of neurogenesis was reported in various
models of CNS injuries and diseases [64, 65]. In MS
brains, immature neurons were found in a subpopulation
of subcortical white matter lesions, which may indicate an
activation of neurogenic processes serving to compensate
neuronal deficits [66]. However, the origin of these cells is
unknown. In contrast to this, specification of stem/pro-
genitor cells seems to be shifted towards the glial lineage
in the SVZ of MS patients compared to the healthy brain,
leading to a diminished generation of Dcx+ neuroblasts
[67]. Increased proliferation and enhanced generation of
immature neurons in the acute stage of EAE was previ-
ously reported by our [16] and other groups [68, 69]. En-
hancement of neurogenesis in EAE is transient [16, 68]
and seems to be specific to the hippocampal neurogenic
niche, whereas in the SVZ, the generation of neuroblasts
is reduced [23].
Our data raised the possibility that enhancement of Wnt
activity may trigger hippocampal neurogenesis in order to
replenish damaged neurons. Regarding this, it was shown
that lentiviral-based overexpression of Wnt3a in the stri-
atum enhances neurogenesis and neuronal differentiation,
leading to an improved neuronal function in the model of
focal ischemic injury [70]. In addition to its neurogenic
role, Wnts may promote axonal regeneration [71], synaptic
transmission [72] and neuronal differentiation [73] in the
injured CNS. Prolonged activation of Wnt signaling by
Wnt-activating small molecule potentiator-1 (WASP-1) in-
fusion into the hippocampus improves cognitive function
in healthy adult mice and rescues memory loss in a mouse
model of Alzheimer’s disease [72]. Our data support these
findings, which already raise a considerable interest in
Wnts regarding the development of novel therapeutic ap-
proaches to treat neuronal injury.
Conclusion
Taken together, our data argue for a role of inflammation
in transient activation of hippocampal Wnt signaling upon
autoimmune mediated injury. Induction of Wnts can be
accounted as a key factor triggering endogenous repair by
engaging the activation of neuronal progenitors in the
hippocampal neurogenic niche. Further experiments are
needed to test whether therapeutic boosting ofWnt activity
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The following mice were used for experiments: 6 weeks
old female SJL/J mice were purchased from Janvier (Le
Genest-St-Isle, France). NestineGFP+ mice [74] were pro-
vided by the animal facility of the University of Düsseldorf.
In these transgenic mice the second intron enhancer of
the rat nestin gene was placed upstream of the minimum
promoter of heat shock protein 68 (HSP68) fused to eGFP
cDNA and a polyadenylation signal. Axin2lacZ/+ [75] were
received from the European Mouse Mutant Archive
(EMMA). In Axin2lacZ/+ mice the lacZ gene, containing a
nuclear localization signal, was introduced in frame to the
endogenous Axin2 (also known as conductin or Axil) by
replacing exon 2 [75]. Axin2 is a direct target of TCF/
LEF1-mediated transcriptional activation that encodes an
inhibitor of the Wnt signaling pathway. All mice were
housed in the animal research facility of the University of
Düsseldorf under specific pathogen free conditions, a
dark/light cycle of 12 h, a stable temperature of 22–24 °C
and unlimited access to food and water.
EAE induction
All experimental procedures were conducted following
the guidelines and protocols approved by the local ani-
mal welfare committee (Landesamt für Natur, Umwelt
und Verbraucherschutz Nordrhein-Westfalen (LANUV);
under protocol numbers G388-11 (active EAE in Axin2-
lacZ/+mice), G197-09 (BrdU injections in EAE mice),
G363-09 (passive EAE in SJL/J)) and follow the animal re-
search: reporting of in vivo experiments (ARRIVE) criteria
and EAE induction guideline [76]. For passive EAE, female
SJL/J mice were subcutaneously immunized with 200 μg
of recombinant proteolipid protein peptide (PLP139–151)
(Pepceuticals) supplemented with 800 μg heat-inactivated
Mycobacterium tuberculosis (strain H37RA, Difco) emulsi-
fied in 200 μl Complete Freund’s Adjuvant (CFA, Sigma-
Aldrich) per mouse. On day 10 post immunization (p.i.),
spleen and lymph node cells were isolated, and the
resulting single-cell suspension was re-stimulated with
PLP139–151 (10 μg/mL) in RPMI 1640 medium supple-
mented with 10 % fetal calf serum (FCS), penicillin/
streptomycin, glutamate, and 2-mercaptoethanol (all
from Invitrogen Life Technologies). After four days in
culture, cells were harvested and injected intraperito-
neal (i.p.) into naive female SJL/J mice (3 × 107 cells per
mouse). Control mice received a single i.p. injection of
PBS. Animals were weighed and scored daily, according
to following clinical scale: 0 (no clinical signs), 1 (tail ple-
gia), 2 (abnormal gait), 3 (hind limb paralysis), 4 (complete
paralysis) to 5 (death or euthanasia) with intervals of 0.5
[16]. Mice were euthanized either on day 6, 20 or 50 post-
transfer. Hippocampi were dissected and stored at −80 °C
for total RNA and protein isolation.
To induce active EAE in the Axin2lacZ/+ mouse strain,
animals were immunized by subcutaneous injection
with 200 μg of recombinant myelin oligodendrocyte
glycoprotein (MOG35–55) peptide (Pepceuticals) in CFA
(Sigma-Aldrich), supplemented with 800 μg heat-
inactivated Mycobacterium tuberculosis (strain H37RA,
Difco). Intraperitoneal injections of 200 ng pertussis toxin
(PTX, Sigma-Aldrich) were performed on the day of
immunization and on day 2 [16]. The control group was
treated with CFA only and with 200 ng pertussis toxin on
day 0 and day 2. Mice were euthanized either on day 20,
30 or 50 post immunization.
β-Galactosidase assay
Tissue or organotypic slices isolated from Axin2lacZ/+
mice were lysed on ice for 15 min in triton-containing
lysis buffer (Applied Biosystems) and cleared by centrifu-
gation at 10,000 g for 10 min at 4 °C. Then protein con-
centration was determined by BCA protein assay kit
(Interchim). 50 μg of protein were applied for measuring
β-galactosidase (β-gal) activity in triplicates using the
“Galactostar Chemiluminescence Kit” (Applied Biosys-
tems) in a white 96-well NUNC plate (Thermo Scientific)
at room temperature (RT) for 2 h using a microplate
reader (TECAN). The maximum of luminescence intensity
for each individual sample was used to calculate mean of
triplicate measurements. Lysates of corresponding β-gal-
negative brain tissues were used to calculate background
intensity.
Western blotting
Hippocampal tissue isolated from EAE mice was lysed on
ice for 15 min in RIPA buffer (50 mM Tris (pH 7.4),
150 mM NaCl, 1 % (v/v) NP40, 0.5 % (v/v) sodium deoxy-
cholate, 0.1 % (v/v) SDS) with protease and phosphatase
inhibitors (Roche). Lysates were cleared by centrifugation
at 14,000 g for 20 min at 4 °C and protein concentration
was determined using a BCA protein assay Kit (Inter-
chim). Protein samples were loaded on 8–16 % gradient
“Mini-Protean TGX” gel (Biorad). Blotting onto a nitro-
cellulose membrane was performed using the “Trans-Blot
Turbo System” (Biorad) for 7 min at 25 Volts. Afterwards,
membranes were incubated with blocking buffer (5 % (v/
v) skimmed milk in 0.05 % (v/v) PBS/Tween) for 1 h at
RT and incubated overnight at 4 °C with following anti-
bodies: mouse anti-neurofilament 160/200 (Sigma-Al-
drich), mouse anti-PSD-95 (Abcam), rabbit anti-β-catenin
(Cell Signalling), mouse anti-active-β-catenin (ABC, Cell
Signalling), mouse anti-β-actin (Sigma-Aldrich). Primary
antibodies were detected by incubation with IR-Dye sec-
ondary antibodies (Li-COR) for 1 h at RT and subsequently
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quantified using the Odyssey infrared imaging system (LI-
COR). Optical density analysis was performed with ImageJ
software (NIH).
RNA isolation, cDNA synthesis and qPCR
RNA was isolated with a RNA isolation Kit (Macherey-
Nagel) or Trizol (Invitrogen Life Technologies). 1 μg of
purified RNA was used for first-strand cDNA synthesis
using “Superscript III Reverse Transcriptase” and oligo(dT)
in a final volume of 20 μl according to manufacturer’s in-
struction (Invitrogen Life Technologies). Real-time quantifi-
cation of gene expression was performed using a SYBR
Green qPCR assay (Applied Biosystems) or TaqMan 5′
FAM- and 3′TAMRA-labeled fluorescent probes (Eurofins
MWG). PCR was performed using an “ABI 7500” real-
time PCR system (Applied Biosystems) with standard cyc-
ling conditions: 40 cycles of 10 s at 95 °C, 60 s at 60 °C.
Specificity of the PCR product was confirmed by examin-
ation of the dissociation reaction plot and PCR product
detection on 2 % agarose gel. The samples were run in
duplicates and the level of expression of each gene was
normalized to the expression of the housekeeping gene
glycerinaldehyd-3-phosphat-dehydrogenase (GAPDH). The
sequences of all PCR primers used are available on request.
Organotypic slice cultures
Organotypic slice cultures (OSCs) were generated from
10 days old Axin2lacZ/+/nestineGFP+ pups as previously
described [77]. Briefly, the hippocampus was cut into
350 μm thick slices using a McIllwain tissue chopper
(GaLa Instrumente). OSCs were dissociated in ice-cold
dissecting medium (Hank’s Balanced Salt Solution (HBSS),
Invitrogen Life Technologies) complemented with penicil-
lin/streptomycin (100 U/ml, Invitrogen Life Technologies),
2.5 mg/ml glucose (Sigma Aldrich) and 10 mM kynurenic
acid (Sigma Aldrich). OSCs were cultured on Millicell-
CM culture plate inserts (Millipore) in culture medium
(50 % (v/v) MEM, 25 % (v/v) HBSS, 25 % (v/v) heat-
inactivated horse serum, 2 mM glutamine, penicillin/
streptomycin (100 U/ml) (all from Invitrogen Life Tech-
nologies) and 2.5 mg/ml glucose (Sigma Aldrich) for 1
week at 37 °C in a humidified atmosphere with 5 % CO2.
At this point OSCs were used for further experiments. For
analysis of β-gal activity and Axin2 gene expression hippo-
campal Axin2lacZ/+ OSCs were cultured for seven days
followed by treatment with Wnt3a (20 ng/ml; R&D Sys-
tems), interferon gamma (IFNγ, 100 U/ml; Immunotools),
TNFα (1 ng/ml; Immunotools) or TNFα (1 ng/ml) with
the inhibitor of Porcn function, IWP-2 (4 μM; R&D Sys-
tems). After 6 h of treatment, the medium was replaced
with fresh cytokine-free medium and OSCs were cultured
for additional 24 h. Afterwards, tissue was either fixed (β-
gal assay; discussed below) or collected for RNA isolation.
For the double treatment with IWP-2, the inhibitor was
all the time present in the media.
For analysis of neurogenesis in hippocampal OSCs, cul-
tures were first pretreated for 24 h with BrdU (0.5 μM,
Sigma) to allow detection of proliferating cells [25]. Next,
recombinant cytokines: TNFα (1 ng/ml), interferon gamma
(IFNγ, 100 U/ml) (both from ImmunoTools) or Wnt3a
(20 ng/ml, R&D Systems) were added to the culture
medium for 6 h, followed by washing and replacement
with cytokine-free media for additional 24 h. IWP-2
(4 μM, R&D Systems) was added at the same time as
the cytokines and was present until the end of the ex-
periment. After this period, slice cultures were directly
used to analyse β-gal activity (see above), RNA isolation
or fixed with aldehydes for histological examination.
Histology
Mice were anaesthetized using isoflurane (Piramal Health-
care) and perfused with PBS. Brain and spinal cord were
dissected and either directly frozen for X-gal staining or
postfixed with 4 % (v/v) paraformaldehyde (PFA, Roth) for
16 h, followed by dehydration in a 25–30 % (v/v) sucrose
solution. Tissue samples were cryopreserved in “Tissue-
Tek” (Sakura Fintek Europe) at −80 °C. For histological
examination brains and spinal cords were cut on a cryostat
(Leica). 20 μm slices were permeabilized with 0.5 % (v/v)
Triton X-100 and blocked in 5 % (v/v) horse serum (Invi-
trogen Life Technologies) and 1 % (v/v) bovine serum albu-
min in PBS for 2 h. OSCs were washed two times in warm
PBS, fixed for 1 h in 4 % PFA and permeabilized for 1 h
with 1 % (v/v) Triton X-100 (Sigma Aldrich) in PBS. Pri-
mary antibodies were diluted in PBS containing 2.5 % (v/v)
horse serum with 0.25 % (v/v) Triton X-100 and incubated
with tissue samples overnight (or 48 h for OSCs) at 4 °C.
Following primary antibodies were used: guinea pig anti-
GFAP (1:1000; Synaptic Systems), rat anti-CD68 (1:350;
Biolegend), goat anti-SOX2 (1:250; Santa Cruz); mouse
anti-iNOS (1:100; BD Transduction Laboratories), rabbit
anti-Iba1 (1:500, Wako Pure Chemical Industries), rabbit
anti-GFP (1:1000, Abcam) goat anti-Doublecortin (Dcx,
1:250, Santa Cruz Biotech) and Hoechst 33342 dye (Mo-
lecular Probes). Visualization was performed by incubation
with fluorescent Cy2-, Cy3- and Cy5-conjugated secondary
antibodies (Millipore) for 1–2 h at RT. Hoechst dye
33258 (Molecular Probes) was used to counterstain nu-
clei followed by mounting on glass slides with “Immuno
Mount” (Thermo Scientific). Immunostainings were ana-
lyzed on an Olympus BX51 microscope and overlaid using
Photoshop 13.0 software (Adobe).
Quantification of Iba1+ and GFAP+ cells in the dentate
gyrus has been performed in four animals per group.
The number of positive cells per animal was calculated
as a mean of labeled cells in mm2 of the DG area in 3–4
sections (200 μm distance between sections). The ratio
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of micron per pixel (1 pixel = 0.16125 μm at magnifica-
tion x 40) was used to calculate the area analyzed.
For X-gal staining, 20 μm thick cryoslices or OSCs,
prepared from Axin2lacZ/+ mice, were fixed with PBS
containing 2 % (v/v) formaldehyde, 0.2 % (v/v) glutaral-
dehyde and 0.02 % (v/v) NP40 (all from Sigma Aldrich)
for 5 min. After washing, slices were incubated for 2 h
at 37 °C in X-gal staining solution, containing 10 mM
K3Fe(CN)6, 10 mM K4Fe(CN)6, 0.02 % (v/v) NP40,
2 mM MgCl2 and X-gal (0.5 mg/ml) (all from Sigma Al-
drich) dissolved in PBS. Samples were fixed with 4 % (v/
v) PFA for 15 min and mounted on glass slides with
“Immuno Mount” (Thermo Scientific).
BrdU treatment and immunostaining
For labeling of proliferating cells, 50 mg/kg body weight
of 5-bromo-20-desoxyuridine (BrdU; Sigma Aldrich) was
injected i.p. daily for five following days starting at the
peak of disease (14 d.p.i.). EAE animals and healthy con-
trols were euthanized and perfused 2 weeks after the
first BrdU-injection. Mouse hippocampi were collected
and cryopreserved (see histology part) and afterwards
processed as previously described [16]. Briefly, sections
were incubated in 2 N HCl for 30 min at 37 °C and
rinsed with 100 mM tetraborate buffer. Sections were
incubated with primary rat anti-BrdU antibody (1:400;
Upstate) and goat anti-Dcx antibody (1:500; Santa Cruz
Biotechnology) overnight at 4 °C, followed by incubation
with appropriate Cy2/Cy3-conjugated secondary anti-
bodies (Millipore) for 1 h at RT.
Primary hippocampal cell cultures
Tissue processing and preparation of mixed glial cell
population
Whole hippocampus from 2 to 5-day-old C57BL/6 mice
were dissected and washed with ice cold HBSS supple-
mented with 0.2 % glucose. Tissue was finely minced
with a razor blade and digested by StemPro Accutase
(Gibco) for 20 min at 37 °C followed by 10 min digestion
with 0.05 % Trypsin-EDTA (Gibco), DNase (250 U/ml,
Worthington). Tissue was rinsed with DMEM supple-
mented with 10 % heat-inactivated fetal calve serum (FCS;
Gibco), gently triturated by passing through a 1-ml sero-
logical pipette until a homogenous suspension appeared
and filtered through a 40 μm cell strainer (BD Biosciences).
Cells were suspended in Neurobasal medium supplemented
with B27, glutamax, 1 % penicillin/streptomycin (all from
Gibco) (hereinafter referred to as NB media).
Microglia and astrocyte cell cultures
Isolated hippocampal cells were plated on poly-ornithine-
coated petri dishes and cultured in 10 ml of NB media
(see above) supplemented with 10 % (v/v) FCS and 20 ng/
ml of macrophage colony stimulating factor (M-CSF;
Immunotools). 50 % of culture media was replaced every
4 days with fresh media. After 2–3 weeks incubation in a
5 % CO2 incubator at 37 °C, cells were collected by dis-
sociation with StemPro Accutase (Gibco) for positive se-
lection of CD11b+ cells or GLAST+ cells using magnetic
microbeads (Miltenyi Biotech), according to the manufac-
turer’s instructions. This approach results in about 90 %
purity of primary microglia cells and 95 % purity of pri-
mary astrocytes determined by immunostaining for Iba-1
and GFAP, respectively. Microglia and astrocytes were
harvested, washed and plated on poly-L-ornitine coated
plates or coverslips at densities appropriate for each assay.
Hippocampal progenitor cultures
Isolated hippocampal cells were cultured in serum-free
proliferating conditions on uncoated Petri plates in NB
supplemented with 20 ng/ml bFGF (Immunotools). After
3–4 days divided cells formed free-floating neurospheres.
bFGF was added every second day. 30 % of culture media
was replaced every 4 days with fresh media. After 1–2
weeks in culture neurospheres were collected and cells
were dissociated by trypsin-EDTA solution. For further
analysis, cells were cultured as adherent cells in prolif-
erating medium on poly-ornithine-coated petri dishes
or glasses. For gene expression analysis cells were
treated for 6 h with mouse recombinant TNFα (0.2 ng/
ml or 1 ng/ml; R&D) or Wnt3a (20 ng/ml; R&D).
Coculture of hippocampal progenitors with microglia
2 × 105 CD11b+ cells in 200 μl NB media were added to
the upper well of each Transwelltm inserts (0.2 μm diam-
eter holes, Ibidi) for 24 h. In parallel, 4 × 104 hippocam-
pal progenitor cells dissociated from neurospheres were
cultured separately on poly-L-ornithine coated coverslips
in proliferating NB media containing 20 ng/ml bFGF.
24 h after culturing of microglia on transwells, cells were
activated with TNFα (1 ng/ml) for 4 h and washed care-
fully with NB media. After this, the transwells containing
microglia were set on hippocampal progenitor cultures
and incubated for 24 h in proliferating NB media (con-
taining 5 ng/ml bFGF) in the presence or absence of sol-
uble Frizzled-8 (sFz8; 1 μg/ml; R&D). 10 μg/ml of BrdU
was added for last 2 h of experiment to allow detection
of proliferating cells. Goat anti-SOX2 (1:250; Santa Cruz)
and rat anti-BrdU (1:500; Upstate) primary antibody
were used to detect mitotically active cells in hippocam-
pal progenitor cultures.
Statistical Analysis
All values in the figures are shown as mean + SEM. Statis-
tical analysis was performed with GraphPad Prism 5
(GraphPad Software). The p values of *p < 0.05; **p < 0.01;
***p < 0.001 were determined to be statistically significant
by using Student’s t-test.
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beta; LANUV, Landesamt für Natur, Umwelt und Ver-
braucherschutz Nordrhein-Westfalen; Lef1, lymphoid
enhancer-binding factor 1; LPC, lysolecithin; MOG,
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sclerosis; NeuroD1, neurogenic differentiation 1; NF-H,
neurofilament-H; OSC, organotypic slice culture; PFA,
paraformaldehyde; PLP, proteolipid protein peptide;
Prox1, prospero homeobox 1; PSD-95, postsynaptic
protein 95; PTX, pertussis toxin; RT, room temperature;
SEM, standard error of mean; SGZ, subgranular zone;
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necrosis factor alpha; WASP-1, Wnt-activating small mol-
ecule potentiator-1.
Additional files
Additional file 1: Figure S1. Upregulation of Wnt activity in the
hippocampus and the spinal cord correlates with disease severity. (a) Iba1
immunostaining (red) of spinal cord sections from Axin2lacZ/+ EAE mice at
day 20. The white dashed line highlights lesion areas; white matter tissue
is outlined by yellow dashed line. Nuclei were counterstained with
Hoechst (blue). Scale bar, 100 μm. (b) Histogram represents the average
number of lesions per section of each EAE time point as mean + SEM.
Spinal cord: day 20 (n = 4; 15–35 sections/mouse), day 30 (n = 3; 10–23
sections/mouse), day 50 (n = 3; 10–17 sections/mouse). (c) Representative
image of lesion site in the DG. Iba1 (red) immunostaining in
hippocampal section from EAE mouse at day 30. Nuclei (grey). Scale bar,
50 μm. (d) Representative image of neural stem cells located in the SGZ.
SOX2 (green) and GFAP (red). Arrowheads indicate SOX2+/GFAP
+ radial glia-like cells and arrows indicate SOX2+/GFAP+ horizontal
progenitors. Nuclei (grey). Scale bar, 25 μm. (e+f) β-gal assay of cortical
and cerebellar EAE tissue revealed no changes in Wnt activity. Histograms
represent mean + SEM of fold-changes of β-gal activity in EAE mice rela-
tive to controls (CFA) set as 1. Day 20 (EAE, n = 6; CFA, n = 3); day 30
(EAE, n = 4; CFA, n = 3); day 50 (EAE, n = 8; CFA, n = 4). (g) qPCR analysis
of Axin2 in different CNS parts in acute EAE (day 20). Data represent mean
of fold-changes + SEM of gene expression in EAE mice (n = 6) relative to
controls (CFA; n = 6) set as 1. Expression of Axin2 was normalized
to Gapdh. (d) Regression analysis shows correlation between β-gal activity
in inflamed CNS tissues and clinical disease score in EAE animals. Pearson
correlation, r = 0.58; p = 0.018 (hippocampus) and r = 0.52, p = 0.036
(spinal cord). Statistics: Two-tailed, unpaired Student’s t-test,* * p < 0.05
and ** p < 0.01. (PDF 6160 kb)
Additional file 2: Figure S2. Gene expression analysis in the
hippocampal tissue of EAE mice. (a) qPCR analysis of selected Wnt
ligands in the hippocampus at early (day 20) and chronic (day 50) stages
of passive EAE. Histogram represents mean + SEM of fold-changes
relative to control group (PBS) set as 1. Gene expression was normal-
ized to Gapdh. Day 20 (EAE, n = 4–6; control, n = 4); day 50 (EAE, n = 8–
13; control, n = 7–11). (b) qPCR analysis of selected Wnt ligands in the
cortex, cerebellum and spinal cord at early stages of passive EAE (day
20). Histogram represents mean + SEM of fold-changes relative to control
group (PBS) set as 1. Gene expression was normalized to Gapdh. Six control
and six EAE mice were analysed for each part of the CNS. n.d. not detect-
able. (c) A regression analysis shows correlation between the TNFα and the
Axin2 gene expression levels examined in hippocampal tissue of individual
EAE animals. Pearson correlation, r = 0.8458; p< 0. 001. (d) qPCR analysis shows
transient upregulation of Smad7 expression in the hippocampus of mice with
passively transferred EAE. Data represent mean + SEM of fold-changes of
gene expression in EAE mice relative to respective controls (PBS) set as
1. Expression was normalized to Gapdh. Day 20 (EAE, n = 4; control, n =
4); day 50 (EAE, n = 4; control, n = 4). Two-tailed, unpaired Student’s t-
test, * p < 0.05 and ** p < 0.01. (PDF 430 kb)
Additional file 3: Figure S3. Effect of TNFα on gene expression of
Axin2 and Wnt ligands in hippocampal cells. (a) The distribution pattern
of LacZ expression in Axin2lacZ/+ hippocampal slice cultures. X-gal stain-
ing of hippocampal slices (postnatal day 10) shows LacZ expression pre-
dominantly in the granular cell layer (gcl). Scale bar, 50 μm. (b)
qPCR analysis of Axin2, Wnt3, Wnt8b and Wnt5a gene expression in hip-
pocampal progenitors after 6 h treatment with TNFα (0.2 ng/ml or
1.0 ng/ml; n = 3) or Wnt3a (20 ng/ml; n = 3). Histogram represents mean
+ SEM of fold-changes of gene expression relative to controls (PBS, n = 3)
set as 1. (c) qPCR analysis of gene expression of selected Wnt ligands in
hippocampal astrocytes (GLAST+) and microglia (CD11b+) cells treated
with TNFα (0.2 ng/ml or 1.0 ng/ml; n = 3) for 6 h. Histogram represents
mean + SEM of fold-changes of gene expression relative to controls
(PBS, n = 3) set as 1. (c) Histological analysis of proliferating cells in the
DG of hippocampal NestineGFP OSCs. Hippocampal slices were cultured
for seven days followed by 6 h treatment with Wnt3a (20 ng/ml) or IFNγ
(100 U/ml) and additional incubation in cytokine-free medium for 24 h.
BrdU was administered for 24 h prior to treatment with cytokines. Repre-
sentative images show BrdU (red) and eGFP (green). Arrow heads indi-
cate BrdU+/eGFP+ co-labeled hippocampal progenitors. Scale bar, 50 μm.
(d) The frequency of BrdU label-retaining cells in the DG of hippocampal
NestineGFP OSCs is increased after treatment with Wnt3a. Data are shown
as mean + SEM of cells per mm of the DG. Control (PBS, n = 15–20 slices);
IFNγ (n = 4–11 slices) and Wnt3a (n = 8–14 slices). Statistics: Two-tailed,
unpaired Student’s t-test,* * p < 0.05, ** p < 0.01 and *** p < 0.001. (PDF
1448 kb)
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